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NRAGE, A Novel MAGE Protein, Interacts with
the p75 Neurotrophin Receptor and Facilitates
Nerve Growth Factor±Dependent Apoptosis
and Shooter, 1994; Hantzopoulos et al., 1994; Verdi and
Anderson, 1994; Ryden et al., 1997). p75NTR increases
Trk receptor ligand specificity by reducing binding of
nonpreferred ligands (Bibel et al., 1999; Brennan et al.,
1999) and by attenuating TrkA activity through intracellu-
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receptors when both are overexpressed (Gargano et al.,
Canada 1997; Bibel et al., 1999).
p75NTR is widely distributed within cells that lack
catalytically active Trk receptors and is capable of au-
tonomous signaling. Numerous studies have shown that
Summary p75NTR can mediate cell death both in vitro and in
vivo (Barrett and Bartlett, 1994; Casaccia-Bonnefil et al.,
The mechanisms employed by the p75 neurotrophin 1996; Frade et al., 1996; Majdan et al., 1997; Coulson
receptor (p75NTR) to mediate neurotrophin-depen- et al., 1999; Frade and Barde, 1999), but the precise
dent apoptosis are poorly defined. Two-hybrid analy- signaling events responsible for this effect are uncertain.
p75NTR causes a neurotrophin-dependent increase ofses were used to identify proteins involved in p75NTR
sphingomyelinase (Dobrowsky et al., 1994, 1995) andapoptotic signaling, and a p75NTR binding partner
c-Jun N-terminal kinase (JNK) activity (Bamji et al., 1998;termed NRAGE (for neurotrophin receptor±interacting
Yoon et al., 1998), but neither of these has been directlyMAGE homolog) was identified. NRAGE binds p75NTR
linked to p75NTR-dependent cell death. p75NTR canin vitro and in vivo, and NRAGE associates with the
also increase NF-kB activation (Carter et al., 1996; Bha-plasma membrane when NGF is bound to p75NTR.
kar et al., 1999), but this pathway appears to antagonize,NRAGE blocks the physical association of p75NTR
rather than facilitate, cell death (Ye et al., 1999; Gentrywith TrkA, and, conversely, TrkA overexpression elimi-
et al., 2000). Other TNF receptor superfamily membersnates NRAGE-mediated NGF-dependent death, indi-
include the apoptotic receptors fas, DR3, DR4, and DR5cating that interactions of NRAGE or TrkA with p75NTR
and the immunomodulatory receptors CD30, CD40, andare functionally and physically exclusive. NRAGE over-
TNF-RII (Baker and Reddy, 1998). The apoptotic recep-
expression facilitates cell cycle arrest and permits tors typically contain an intracellular self-associating
NGF-dependent apoptosis within sympathetic neuron protein±protein interaction motif known as the death
precursors cells. Our results show that NRAGE con- domain, which allows them to couple to the caspase
tributes to p75NTR-dependent cell death and suggest cascade through cytosolic adaptor proteins such as
novel functions for MAGE family proteins. FADD and TRADD. p75NTR contains an intracellular re-
gion that resembles the death domain (Chapman, 1995),
Introduction but it shows crucial structural differences compared to
the fas death domain (Huang et al., 1996; Liepinsh et
The neurotrophins are a family of growth factors whose al., 1997) and does not self-associate or bind to FADD,
functions include the regulation of neuronal survival, TRADD, or RIP (Varfolomeev et al., 1996; Nichols et al.,
differentiation, axonal and dendritic growth, and synap- 1998). The p75NTR death domain not mediate apoptosis
tic activity (Farinas, 1999; McAllister et al., 1999). Neuro- when present in the context of a fasECD-p75ICD chimeric
trophins exert their effects by binding two types of cell receptor (Liepinsh et al., 1997; Kong et al., 1999), indicat-
surface receptors. The Trk receptors are receptor tyro- ing that the apoptotic signaling mechanism of p75NTR
sine kinases that selectively bind different members of differs from that of other TNF receptor superfamily
the neurotrophin family, with TrkA preferentially binding members.
nerve growth factor (NGF), TrkB selectively binding Several potential p75NTR interacting proteins have
brain-derived neurotrophic factor (BDNF) and neuro- recently been identified. Many TNF receptor superfamily
trophin-4/5 (NT-4/5), and TrkC interacting only with members activate JNK and NF-kB signaling pathways
neurotrophin-3 (NT-3). The second class of neurotro- through a group of interacting factors termed the TRAF
phin receptor contains the p75 neurotrophin receptor proteins (Wajant et al., 1999), and several TRAF family
(p75NTR), a member of the TNF receptor superfamily members bind the juxtamembrane region of p75NTR
that binds each of the neurotrophins (Frade and Barde, when overexpressed in 293 cells (Khursigara et al., 1999;
1998). Ye et al., 1999). Two novel p75NTR interactors, SC-1
When p75NTR and TrkA are coexpressed, p75NTR (Chittka and Chao, 1999) and NRIF (Casademunt et al.,
facilitates NGF binding to TrkA and thereby enhances 1999), have recently been identified, and in a surprising
TrkA activation and NGF-dependent survival (Barker development Barde's group has shown that amphiphilic
sequences within the p75NTR death domain bind the
rhoA GTPase (Yamashita et al., 1999). Determining the³ To whom correspondence should be addressed (e-mail: mdpb@
musica.mcgill.ca). contribution of each of these to p75NTR-dependent cell
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death in appropriate physiological settings remains a
major challenge.
To gain insights into p75NTR function, two-hybrid
analyses were used to identify p75NTR interactors and
a novel p75NTR interacting protein termed NRAGE was
identified. NRAGE binds p75NTR in vitro and p75NTR
and NRAGE can be coimmunoprecipitated from un-
transfected cells that endogenously express both pro-
teins. The subcellular distribution of NRAGE is altered by
NGF binding to p75NTR, and overexpression of NRAGE
disrupts the physical association of p75NTR with TrkA.
NRAGE facilitates growth arrest and is required for
p75NTR-dependent apoptosis in sympathetic precursor
cells. These data show that NRAGE is an important me-
diator of p75NTR signaling and provide new insights
into the physiological roles of MAGE family members.
Results
A whole mouse E13±E15 yeast two-hybrid library was
screened using the entire rat p75NTR intracellular do-
main as bait, and a single 0.9 kb clone that activated
both LacZ and HIS3 transcription in the presence of the
p75NTR bait was identified. This cDNA fragment was
used to screen a rat neural crest cell cDNA library, and
the largest clone identified (2.9 kb) was sequenced. This
clone hybridized with a single 3.0 kb mRNA on Northern
blots (data not shown) and therefore represents a near
full-length cDNA. The largest open reading frame is 2328
nucleotides in length and encodes a 775 amino acid
protein with a predicted molecular weight of 85,792 Da.
We have named this protein NRAGE for neurotrophin
receptor±interacting MAGE homolog (see below). The
cDNA fragment identified in the two-hybrid screen en-
codes a 300 amino acid fragment and was designated
Figure 1. NRAGE Amino Acid Sequence and HomologiesNRAGE410±709. Human NRAGE is represented in the TIGR
(A) Alignment of rat and human NRAGE amino acid sequences. Thedatabase by a series of overlapping clones designated
lightly shaded area shows the interspersed repeat domain, and theTHC252649. Sequencing of IMAGE cDNA clones repre-
darker area indicates the MAGE homology domain. The line indi-senting full-length human NRAGE revealed that the rat
cates amino acids 410±709, which reflects the fragment initiallyand human forms of NRAGE are 87% identical overall
identified by two-hybrid screening.
with 97% identity in the C-terminal 315 amino acids (B) Dendrogram showing the relatedness of the MAGE homology
(Figure 1A). domains of NRAGE and other MAGE family members.
BLAST searches revealed that NRAGE belongs to the
MAGE family, a group of z25 proteins distinguished
by the presence of a 200 amino acid MAGE homology binding protein (MBP) fused to either the entire p75NTR
intracellular domain (MBP-ICD, amino acids 276±425)domain. The functional roles of most of the proteins in
this class are unknown, but one family member, Necdin, or the p75NTR death domain (MBP-DD, amino acids
329±425). Figure 2B shows that NRAGE-GST readilyhas been implicated in cell cycle control. Necdin and
several other MAGE family members consist of little bound the MBP-ICD fusion protein but failed to associ-
ate with MBP-DD, indicating that the critical binding de-more than the MAGE homology domain but others
(nM15, MAGE-like, and KIAA1114) are larger proteins terminants for NRAGE association are in the p75NTR juxta-
membrane domain. To test whether full-length NRAGEand show loose homology to NRAGE across most of its
length (data not shown). A dendrogram showing the interacts with intact p75NTR when both are overex-
pressed in vivo, full-length Myc-tagged NRAGE wasrelatedness of the NRAGE MAGE homology domain to
others in the family in shown in Figure 1B. NRAGE shows transfected into COS7 cells in the presence or absence
of p75NTR, and lysates were immunoprecipitated withno significant homologies to proteins outside of the
MAGE family but contains an unusual interspersed re- MC192, a p75NTR-specific monoclonal antibody. Figure
2C shows that NRAGE specifically coimmunoprecipi-peat consisting of 25 hexameric units with a WQXPXX
consensus sequence (Figure 1A). tated with MC192 but only when p75NTR was present.
We were concerned that these overexpression para-To verify the p75NTR-NRAGE interaction biochemi-
cally, in vitro pulldown assays were performed. Figure digms may force nonphysiological interactions and
therefore confirmed the presence of a p75NTR-NRAGE2A shows that the p75NTR intracellular domain fused
to glutathione S-transferase (GST) efficiently bound in complex within untransfected PC12nnr5 cells, which ex-
press p75NTR and NRAGE but lack Trk receptor expres-vitro±translated NRAGE410±709, whereas GST alone did not
bind this protein. In separate experiments, NRAGE410±709 sion. Figure 2D shows that endogenous NRAGE was
specifically coimmunoprecipitated with p75NTR fromwas fused to GST and used in pullouts with maltose
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Figure 2. NRAGE Binds p75NTR In Vitro and
In Vivo
(A) GST or GST-p75NTR-ICD fusion proteins
prebound to glutathione beads were incu-
bated with 35S-labeled NRAGE410±709 produced
by in vitro transcription/translation. Pellets
were precipitated and washed, and bound
proteins were visualized by fluorography after
SDS±PAGE. Two repeats of identical experi-
ments are shown.
(B) Equal amounts (z10 mg) of MBP-DD (lanes
1 and 2) or MBP-ICD (lanes 3 and 4) fusion
proteins were incubated with GST or GST-
NRAGE410±709 (denoted GST-NR) prebound to
glutathione beads. Interacting proteins were
detected by Western blotting using an anti-
MBP antibody.
(C) COS7 cells were transfected with full-
length Myc-tagged NRAGE in the presence
and absence of p75NTR. Cells were lysed and
immunoprecipitated with a p75NTR mono-
clonal antibody and immunoblotted with
9E10 to detect the Myc-tagged protein. The
top panel shows that NRAGE was coimmuno-
precipitated only when p75NTR was present. Expression of NRAGE and p75NTR in cell lysates is shown in the middle and bottom panels,
respectively.
(D) p75NTR was immunoprecipitated from lysates of PC12nnr5 cells with MC192 and immunoblotted with a polyclonal antibody against the
NRAGE N terminus. MOPC21 and 9E10 were used as isotype-specific antibody controls for the immunoprecipitation. Each of the experiments
shown in (A) through (D) have been repeated a minimum of three times with identical results.
PC12nnr5 cells, indicating that p75NTR and NRAGE in- cord. To examine NRAGE expression at later stages of
teract under physiological conditions. development, affinity-purified NRAGE antibodies were
To examine the embryonic expression of NRAGE used to immunoblot tissue extracts prepared from E18
mRNA, whole-mount in situ hybridization studies were rat embryos and from adult rats. Figure 3B shows that
performed on rat embryos at embryonic age E11.5 using extracts from all E18 tissues show detectable levels of
cDNA probes corresponding to the 59-untranslated re- NRAGE expression, with highest levels within the cortex
gion of the rat NRAGE cDNA. Figure 3A shows that and cerebellum. However, by adulthood, NRAGE levels
NRAGE is expressed at low levels throughout the em- have decreased markedly in all tissues and are detect-
bryo and is enriched in the developing brain and spinal able only within cortex and lung.
To determine if NRAGE and p75NTR are colocalized
in the developing nervous system, double-label immu-
nofluorescence studies were performed on E14 rat. Fig-
ures 4A and 4B show staining of the developing medulla
oblongata with affinity-purified NRAGE antibodies com-
pared to control antibodies and shows NRAGE is highly
expressed in the proliferating and marginal zones but
excluded from the mantle zone (Figures 4A and 4C).
p75NTR is not expressed within the proliferating zone
but is abundant in the marginal and mantle zones (Figure
4D), and p75NTR and NRAGE are therefore initially coex-
pressed in the mantle zone, a region where p75NTR has
been shown to mediate developmental apoptosis (Frade
and Barde, 1999). p75NTR and NRAGE coexpression is
also observed in many other regions of the developing
nervous system, including the trigeminal and dorsal root
sensory ganglia (data not shown) and within the facial
motor nucleus (Figures 4E and 4F). In motoneurons,
p75NTR is present on both cell bodies and processes
of the cells, whereas NRAGE is detected only within cell
Figure 3. Developmental and Tissue-Specific Expression of NRAGE bodies.
(A) Whole mount in situ hybridization of E11.5 rat embryos shows To examine the subcellular compartmentalization of
that NRAGE mRNA is enriched in the developing nervous system. NRAGE, biochemical fractionation studies were per-
(B) Twenty micrograms of tissues lysates derived from E18 rat em- formed (Figure 5). In untreated PC12nnr5 cells, NRAGE
bryos and adult rats (.3 months) were separated by SDS±PAGE
is located mainly in the cytosol, with lower levels presentand immunoblotted using an affinity-purified NRAGE polyclonal anti-
on the plasma membrane and within nuclei. However,body directed against C-terminal peptide 1 (see Experimental Pro-
NGF treatment results in NRAGE accumulation incedures). Expression is particularly high in the developing CNS and
is reduced in all tissues with increased age. plasma membrane fractions within 30 min, and these
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Figure 4. NRAGE and p75NTR Are Coexpressed in the Developing Nervous System
Double-label immunocytochemistry was performed using affinity-purified antibodies directed against NRAGE (A, D, and F) and using MC192,
a p75NTR-specific monoclonal antibody (E and F). (A) through (D) show NRAGE and p75NTR within E14 medulla oblongata ([C] and [D]
approximate the boxed area shown in [A]) and (E) and (F) show NRAGE and p75NTR within the E14 facial motor nucleus. (B) was stained with
purified nonspecific rabbit IgG using the same conditions as for NRAGE staining. Bars in (A), (D), and (F) represent 500, 50, and 30 mM,
respectively. Experiments in (A) through (H) have been repeated at least twice with identical results. Abbreviations: mn, mantle zone; mr,
marginal zone; p, proliferative zone.
levels increase further with longer NGF exposures. Syn- The normal cellular functions of most MAGE family
members are unknown but Necdin inhibits cell cycletaxin 1 and Histone 3 levels were assessed to monitor
the quality of the isolated organelles and revealed ap- progression in 3T3, COS, and 293 cells (Hayashi et al.,
1995; Taniura et al., 1998, 1999). To begin to dissectpropriate enrichment of the plasmalemmal and nuclear
fractions. The compartmental distribution of p75NTR the mechanism by which NRAGE may affect p75NTR-
dependent signaling, NRAGE was examined for effectswas identical to that of syntaxin 1 (data not shown) and
neither p75NTR, syntaxin 1, or Histone 3 showed any on cell cycle progression. To address this, an enhanced
green fluorescent protein NRAGE fusion protein (EGFP-recompartmentalization in response to NGF treatment.
p75NTR and TrkA receptors are coexpressed in sev- NRAGE) was transfected into 293 cells, and cells were
exposed to a 1 hr bromodeoxyuridine (BrdU) pulse ateral neuronal populations and can be coimmunoprecipi-
tated when overexpressed in Sf9 or 293 cells (Gargano either 24, 36, or 48 hr after transfection and then ana-
lyzed for BrdU incorporation by immunocytochemistryet al., 1997; Bibel et al., 1999). To determine if p75NTR-
TrkA complexes contain NRAGE, p75NTR and TrkA were (Figure 7). In untransfected cells or in cells expressing
a control EGFP protein, z40% of cells incorporate BrdU,transiently expressed in 293 cells in the absence and
presence of NRAGE410±709, the NRAGE fragment originally but in cells expressing the NRAGE-EGFP fusion, the
BrdU labeling rate dropped below 5%±10% at each ofidentified in the yeast two-hybrid screen. p75NTR was
immunoprecipitated and immune complexes were ex- the three time points, indicating that NRAGE overex-
pression strongly retards cell cycle progression.amined for the presence of TrkA by immunoblotting.
When only TrkA and p75NTR were coexpressed, TrkA To test if NRAGE plays a role in p75NTR-mediated
cell death, we used native MAH cells, a sympathoad-readily coimmunoprecipitated with p75NTR, but expres-
sion of the NRAGE fragment with the two receptors renal cell line that lack p75NTR and TrkA receptors, or
MAHp75NTR cells, which stably overexpress the receptorconsistently prevented coimmunoprecipitation of TrkA
with p75NTR (Figure 6). We made rigorous attempts to (Figure 8A). In the absence of added neurotrophin,
NRAGE overexpression had no effect on the viability ofidentify endogenous or epitope-tagged full-length NRAGE
or NRAGE410±709 within TrkA immunoprecipitates and MAH cells or MAHp75NTR cells, and NGF treatment of MAH
cells overexpressing NRAGE did not affect survival.within p75NTR-TrkA coimmunoprecipitates derived
from several transfected cell lines, but NRAGE was not However, MAHp75NTR cells that were transfected with
NRAGE cDNA and exposed to NGF showed a highlydetected within the coimmunoprecipitates (data not
shown). This indicates that p75NTR is capable of form- significant reduction in survival (Figure 8B), which was
accompanied by DNA nucleosomal laddering, a bio-ing independent complexes with TrkA or NRAGE but
that a tripartite complex containing all three molecules chemical hallmark of apoptosis (data not shown). BDNF
and NT-3 had no effect on the survival of these cells,is not formed.
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Figure 6. Overexpression of NRAGE Disrupts the p75NTR-TrkA
complex
TrkA was overexpressed in 293 cells either alone, with NRAGE410±709,
with p75NTR, or with NRAGE410±709 and p75NTR. p75NTR was immu-
noprecipitated with REX, and immunoprecipitates were examined
for the presence of coimmunoprecipitating TrkA by immunoblotting
using a polyclonal anti-TrkA antibody (RTA). This experiment has
been repeated four times with similar results.
Figure 5. The Cellular Localization of NRAGE Changes with p75NTR
Activation
when both are overexpressed in COS7 cells, and the twoPC12nnr5 cells were treated with NGF (100 ng/ml) for indicated
times and then lysed in detergent-free buffer and fractionated by molecules form a complex in untransfected PC12nnr5
differential centrifugation. Fractions (20 mg) were analyzed by immu- cells. NRAGE therefore meets all criteria expected for
noblot using antibodies directed against NRAGE, syntaxin, or His- a physiologically relevant p75NTR interacting protein.
tone 3. This experiment has been repeated three times with similar An important physiological function of p75NTR is to
results. modulate responses of the Trk receptors to the neuro-
trophins (Barker, 1998; Barrett, 2000). When overexpres-
sed, p75NTR and TrkA form a coimmunoprecipitable
indicating that this effect was NGF specific. Finally, we complex, and it is likely that formation of a p75NTR-Trk
tested whether MAHp75NTR cells expressing NRAGE and complex is necessary for the functional interactions of
TrkA exhibited NGF-mediated death. Figure 7 shows these two receptors (Gargano et al., 1997; Bibel et al.,
that NGF treatment of these cells did not reduce viability 1999). We have shown that NRAGE410±709 antagonizes the
but instead facilitated survival, presumably through the formation of a p75NTR-TrkA complex and found that
activation of TrkA-dependent survival pathways. These NRAGE is not present in p75NTR immunoprecipitates
data suggest that NRAGE forms part of a NGF-specific that contain TrkA. These experiments are important for
p75NTR apoptotic signaling cascade in sympathoad- two reasons. First, they strongly support the hypothesis
renal cells and that the apoptotic effect of NRAGE is that NRAGE is a bona fide p75NTR interactor. Second,
antagonized by TrkA. they indicate that the formation of p75NTR-TrkA and
p75NTR-NRAGE complexes are mutually exclusive. Our
Discussion studies show that MAH cells, that overexpress NRAGE
and p75NTR undergo cell death in an NGF-dependent
manner, but when TrkA is present the p75NTR-NRAGESubstantial evidence supports the hypothesis that
p75NTR activates autonomous signaling pathways that apoptotic signal is suppressed. These findings show
that NRAGE can contribute to the p75NTR-mediatedcan result in apoptosis in a number of distinct cell types,
but the mechanisms responsible remain unclear (Bar- apoptotic response and are consistent with previous
studies which have suggested that signaling functionsrett, 2000). To identify molecules involved in p75NTR
signaling, we performed yeast two-hybrid screens and of p75NTR and TrkA are mutually antagonistic (Majdan
and Miller, 1999).identified a novel protein termed NRAGE. NRAGE asso-
ciates with the cytosolic domain of p75NTR in yeast, in NRAGE is a member of the MAGE family, a large group
of proteins that all contain a well-conserved z200 aminovitro, and in mammalian cells. The NRAGE fragment
does not bind the p75NTR death domain but rather inter- acid region known as the MAGE homology domain (Itoh
et al., 1996; Kirkin et al., 1998). Many of these proteinsacts with the 80 amino acid intracellular juxtamembrane
domain of p75NTR. p75NTR binds full-length NRAGE consist of little more than the MAGE homology domain
Neuron
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Figure 7. NRAGE Overexpression Results in Cell Cycle Arrest
(A) 293 cells transfected with a GFP-NRAGE fusion protein for 36
hr were incubated with BrdU for 1 hr and then fixed for immunocyto-
chemistry. GFP fluorescence does not withstand the conditions
used for BrdU detection, and therefore the NRAGE-GFP fusion pro-
tein was detected immunocytochemically using a GFP-specific anti-
body. GFP-NRAGE-positive and -negative cells are indicated by
right and left arrows, respectively, in all panels. The top left panel
Figure 8. NRAGE and p75NTR Overexpression Results in Cellularshows GFP-NRAGE, the bottom left panel shows BrdU staining,
Apoptosis in MAH Cellsand the top right panel shows nuclear DNA stained with Hoescht
33258. The bottom right panel is an overlay of (A), (B), and (C) (A) Untransfected MAH cells, MAH cells stably expressing p75NTR,
and shows that the GFP-NRAGE-containing cells are typically BrdU or MAH cells coexpressing p75NTR and TrkA were infected with
negative. control retrovirus or with retrovirus driving NRAGE cDNA. After se-
(B) Cells were scored for BrdU labeling as a function of NRAGE lection in G418, individual lines were pooled. Control MAH cells
expression by a naõÈve observer (n . 200 per experiment). Results were compared to transfected MAH cells for expression of p75NTR,
of cell counts from a representative experiment are shown. NRAGE, and TrkA by immunoblot.
Experiments in (A) and (B) have been repeated at least three times. (B) Transfected MAH cells were assayed for neurotrophin-depen-
dent survival after exposure to 100 ng/ml neurotrophin for 48 hr.
Abbreviations: N, NGF; B, BDNF; 39, NT-3. Standard deviations
shown; *p , 0.01.and a small amount of flanking sequence, but others
have an extended domain structure which resembles
that of NRAGE. Most of the MAGE genes are highly
expressed during development but are present at much Hayashi et al., 1995; Maruyama, 1996), and it has been
hypothesized to facilitate the transition from a cyclinglower levels in the adult (Imai et al., 1995; Kocher et al.,
1995; De Smet et al., 1997; Jurk et al., 1998). However, cell to a postmitotic state. Mice lacking the Necdin gene
appear to develop normally in utero but typically dieexpression of many MAGE genes increases markedly
in numerous cancers due to gene demethylation (De shortly after birth due to postnatal respiratory distress
(Gerard et al., 1999). Intriguingly, Necdin has been re-Smet et al., 1996, 1999), and cytosolic MAGE proteins
that are expressed in malignant cells are proteolyzed cently identified as a candidate gene for Prader-Willi
Syndrome (PWS), a common neurogenetic disorder thatto peptides and are transported into the endoplasmic
reticulum and then presented on the cell surface as results in early transient respiratory distress and hypoto-
nia, which is followed by mental retardation and hyper-antigenic MHC-associated peptides (Traversari et al.,
1992; Bueler and Mulligan, 1996; Kawakami et al., 1996; phagia (Jay et al., 1997; MacDonald and Wevrick, 1997;
Sutcliffe et al., 1997).Itoh et al., 1997; Van den Eynde and Boon, 1997). The
normal intracellular role of most members of this gene Given the structural homology of NRAGE and Necdin,
it is likely that NRAGE and Necdin mediate cell cyclefamily remains completely unknown.
The only MAGE family member that has been function- effects through a shared mechanism. The effect of
NRAGE on both cell cycle and apoptosis raises theally characterized is Necdin, which was originally identi-
fied in a screen designed to identify proteins involved intriguing possibility that the apoptotic effect of p75NTR
may be secondary to cell cycle disruption. It is interest-in the neural differentiation of P19 cells (Maruyama et
al., 1991). Overexpression of Necdin causes cell cycle ing in this regard that SC-1 produces growth arrest when
overexpressed (Chittka and Chao, 1999) and that ZacI,arrest in NIH3T3, HEK293, and SAOS2 cells (Hayashi et
al., 1995; Taniura et al., 1998) through mechanisms that an NRIF homolog, mediates cell cycle arrest and apo-
ptosis (Spengler et al., 1997). It is conceivable, therefore,may involve physical interactions with E2F-1 or p53
(Taniura et al., 1998, 1999). Necdin expression increases that p75NTR-initiated apoptotic signals are transduced
through a complex of molecules that may activate a cellas neurons become postmitotic (Aizawa et al., 1992;
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1mg/ml leupeptin, 5mM DTT, and 5% dry skim milk powder. Diluentscycle±related mechanism distinct from the apoptotic
were precleared with unbound glutathione-Sepharose beads (Phar-pathway used by other members of the TNF receptor
macia) for 1 hr and then supplemented with glutathione beads cou-superfamily. A link between apoptosis and cell cycle
pled to 25 mg of appropriate GST fusion protein. After a 1 hr incuba-disruption has been shown in several neuronal death
tion at 48C, samples were washed extensively in pulldown buffer
paradigms, and it is becoming increasingly accepted lacking 5% milk and eluted from beads by boiling in SDS±PAGE
that cell cycle disruptions may be an important mecha- sample buffer. Samples were analyzed on parallel SDS±PAGE gels,
nism for initiating neuronal death (Freeman et al., 1994; which were either Coomassie stained to confirm equivalent fusion
Herrup and Busser, 1995; Park et al., 1997a, 1997b). protein loading or processed for fluorography using En3Hance (Du-
pont). In separate experiments, MBP-p75NTR-DD or MBP-p75NTR-Recent findings indicate that p75NTR-mediated death
ICD were diluted in pulldown buffer and then incubated for 1 hr atof retinal cells is associated with an increase in cyclin
48C with GST or GST-NRAGE (amino acids 410±709) prebound toB2 levels and can be blocked using roscovitine, a CDK
glutathione S-transferase beads. Samples were washed and pre-inhibitor (Frade, 2000), consistent with the hypothesis
pared for immunoblotting as above.that p75NTR mediates apoptosis through a cell cycle±
dependent pathway that may involve NRAGE. p75NTR
Polyclonal Antibody Generationand NRAGE are coexpressed in many central and pe-
Rabbit polyclonal antibodies against NRAGE were initially produced
ripheral ganglia as well as in the intermediate zone, against keyhole limpet hemocyanin±coupled peptides (peptide 1:
where p75NTR has been shown to play a role in develop- EAEARAEARNRMGIGDE, peptide 2: GPWSWDDIEFELLTWDEE) de-
mental apoptosis (Frade and Barde, 1999). It may be rived from the COOH-terminal region of NRAGE; these were ade-
significant that p75NTR expression in the developing quate for immunoblotting only. To produce antibodies for immuno-
cytochemistry, a PCR product representing amino acids 53±295 ofspinal cord occurs in the region where neurons are un-
rat NRAGE was cloned into pGEX1, sequenced to confirm fidelity,dergoing their terminal mitosis, since it is conceivable
and then used to produce a GST-NRAGE fusion protein that wasthat p75NTR may contribute to cell cycle exit as well as
purified over glutathione columns and used to immunize rabbits.apoptosis. It is likely that studies that directly address
Antibodies were affinity purified as described (Sharp et al., 1993),the role of p75NTR in early nervous system development
with anti-peptide antibodies purified on GST-NRAGE410±709 and anti-
will provide new insights into the physiological role of bodies against the GST-NRAGE53±295 purified on His6-taggedthe receptor. NRAGE53±295.
In conclusion, NRAGE binds p75NTR under phys-
iological conditions, antagonizes the association of Transfections and Immunoprecipitations
p75NTR with TrkA, inhibits cell cycle progression, and For immunoprecipitations involving transient transfections of 293
facilitates p75NTR-mediated apoptosis. The discovery cells, expression plasmids for TrkA (7 mg), p75NTR (3 mg), and
NRAGE410±709 (5 mg) were cotransfected into cells on 100 mm platesthat NRAGE is a p75NTR interactor is consistent with the
by calcium phosphate precipitation. For immunoprecipitations in-hypothesis that p75NTR mediates neuronal apoptosis
volving COS7 cells, 5 mg of expression plasmids encoding eitherthrough interactions with cell cycle regulatory events.
N-terminal Myc epitope±tagged full-length NRAGE, p75NTR, or
empty vector were transfected into cells on 100 mm plates usingExperimental Procedures
lipofectamine (Gibco BRL) as per the manufacturer's instructions.
An expression plasmid (100 ng) driving expression of enhancedTwo-Hybrid Screening, cDNA Cloning,
GFP (pEGFP-N1, Clontech) was included to monitor transfectionand Sequence Analyses
efficiency. Forty-eight hours after transfection, plates were placedThe yeast strain PJ694A (MAT Trp1-901, Leu2-3112 ura3-52, HIS3-
on ice, rinsed with ice-cold Tris-buffered saline (10 mM Tris [pH200 gal4, gal80, Lys2::Gal1-HIS3, Gal2-Ade2, Met2::Gal7-LacZ) was
8.0], 137 mM NaCl), and then lysed with 1 ml of CHAPs lysis bufferthe gift of Philip James (University of Wisconsin) and was cultured
(10 mM Tris [pH 8.0], 150 mM NaCl, 0.7% CHAPs, 10% glycerol,as described (James et al., 1996). The bait p75NTR intracellular
1 mg/ml leupeptin, 1mg/ml aprotinin, 1 mM phenylmethylsulfonyldomain was generated by PCR amplification from full-length rat
fluoride, and 1 mM orthovanadate). For immunoprecipitations in-p75NTR cDNA and cloned into the XbaI sites of plasmid pGAD424
volving PC12nnr5 cells, cells maintained in normal growth media(Clontech). A rat neural crest cell cDNA library was produced in
were first rinsed with ice-cold Tris-buffered saline (10 mM Tris [pHLambda Zap (Stratagene) and was screened using the 0.9 kb NRAGE
8.0], 150 mM NaCl) and then lysed with 1 ml of NP-40 lysis bufferidentified in the yeast two-hybrid screen using standard hybridiza-
(10 mM Tris [pH 8.0], 150 mM NaCl, 1% NP-40, 10% glycerol, 1 mg/tion techniques. Several overlapping clones were identified and se-
ml leupeptin, 1ug/ml aprotinin, 1 mM phenylmethylsulfonyl fluoride,quenced. The longest of these, designated MNCM20, contained the
and 1 mM orthovanadate). In all cases, nuclei were removed byentire predicted 775 amino acid open reading frame. The NRAGE
centrifugation (10,000 3 g, 5 min), and the lysates were preclearedsequence was compared with known and predicted sequences us-
by incubation for 1 hr at 48C with 30 ml of Sepharose beads. Theing web servers operated by the National Center for Biotechnology
beads were removed by centrifugation, and supernatant was incu-Information and the Institute for Genomic Research (TIGR). THC
bated with either 7 ml of REX, a polyclonal antiserum directed against#252649 on the TIGR database was identifed as the human homolog
the p75NTR extracellular domain; with 5 mg of MC192; or with 5of NRAGE, and full-length NRAGE human clones were obtained
mg of control antibodies, as indicated in the figure legends. Afterfrom Research Genetics and sequenced. Alignments of human and
incubating for 2 hr at 48C, samples were supplemented with 30 mlrat NRAGE were performed on the web server operated by the
of protein G-Sepharose (for monoclonal primaries) or 30 ml of proteinNational Center for Biotechnology Information, and dendrograms
A sepharose (for polyclonal primaries) at 48C for 60 min. Forwere produced using the PROTDIST and BIONJ programs on the
PC12nnr5 cells, the lysates were divided into three identical aliquotsweb server at http://bioweb.pasteur.fr. NRAGE sequences depos-
prior to the addition of three isotype-matched primary antibodies.ited in GenBank have been assigned accession numbers AF217963
In all cases, beads were pelleted and washed three times in lysis(human) and AF217964 (rat).
buffer, resuspended in SDS±PAGE sample buffer, and processed
for immunoblot analyses as indicated in the figure legends.In Vitro Translation and Pulldown Experiments
For pulldown experiments, polypeptides containing amino acids
410±709 of NRAGE (the 0.9 kb fragment identified from two-hybrid Tissue Lysates and Subcellular Fractionation
Lysates were prepared from dissected embryonic or adult tissuesscreening) were produced as 35S-labeled proteins using an in vitro
transcription/translation kit (Promega) and then diluted in pulldown by solubilizing in NP40 lysis buffer (1:5, w/v) and centrifuging at
10,000 3 g for 30 min to remove insoluble material. For subcellularbuffer containing 10 mM Tris-OH (pH 8.0), 150 mM NaCl, 1% NP40,
10% glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 mg/ml aprotinin, fractionation studies, PC12nnr5 cells were left untreated or treated
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